Ticarcillin and clavulanic acid in combination were tested against 40 Pseudomonas aeruginosa isolates resistant to ticarcillin by disk diffusion. A total of 21 isolates (53%) were susceptible to ticarcillin-clavulanate by disk diffusion, under currently recommended criteria for ticarcilin susceptibility. Macro-broth dilution tests (ticarcillin plus clavulanic acid, 2 ,ug/ml) confirmed susceptibility (MIC <64 4g/ml) of only 8 (38%) of 21 isolates. Time-kill studies of disk diffusion susceptible isolates indicated 2 log10 or greater killing of most isolates at 6 h in broth containing ticarcillin (64 ,ig/ml) combined with clavulanic acid (1, 2, 5, or 10 ,ug/ml). After 6 h, regrowth was common in all concentrations of clavulanic acid except 10 ,ug/ml. Regrowth populations were resistant to ticarcillin-clavulanate by MIC determination. Poor bactericidal activity of ticarcillin-clavulanate against ticarcillin-resistant P. aeruginosa was confirmed, as most isolates did not undergo 99.9% or greater killing at 24 h in all concentrations of clavulanic acid. Serotype 0-11 was our most common serotype and was associated with disk diffusion "pseudosusceptibility." Concomitant disk diffusion testing of ticarcillinclavulanate and ticarcillin is recommended for testing the susceptibility of P. aeruginosa to ticarcillinclavulanate by disk diffusion. P. aeruginosa isolates resistant to ticarcillin should as a rule be considered also resistant to ticarcillin-clavulanate, despite apparent susceptibility by disk diffusion.Clavulanic acid, by virtue of its irreversible inhibition of Richmond type II, III, IV, and V P-lactamases (18,22), has broadened the spectrum of activity of ticarcillin to include many otherwise resistant strains of Staphylococcus aureus, the family Enterobacteriaceae, and Bacteroides spp. (2, 6-8, 11, 15, 19). Against ticarcillin-susceptible Pseudomonas aeruginosa, ticarcillin-clavulanate in combination has activity in vitro like that of ticarcillin alone (2,6,8,11,15).